Cytotoxicity, mode of action and antibacterial activities of selected Saudi Arabian medicinal plants by unknown
Kuete et al. BMC Complementary and Alternative Medicine 2013, 13:354
http://www.biomedcentral.com/1472-6882/13/354RESEARCH ARTICLE Open AccessCytotoxicity, mode of action and antibacterial
activities of selected Saudi Arabian medicinal
plants
Victor Kuete1,2, Benjamin Wiench1, Mansour S Alsaid3, Muhammad A Alyahya3, Aimé G Fankam2,
Abdelaaty A Shahat3,4* and Thomas Efferth1*Abstract
Background: The flora of Saudi Arabia is one of the richest biodiversity areas in the Arabian Peninsula and
comprises very important genetic resources of crop and medicinal plants. The present study was designed to
investigate the cytotoxicity and the antibacterial activities of the organic extracts from twenty six Saudi Arabian
medicinal plants. The study was also extended to the investigation of the effects of the extracts from the four best
plants, Ononis serrata (SY160), Haplophyllum tuberculatum (SY177), Pulicaria crispa (SY179), and Achillea beiberstenii
(SY-200) on cell cycle distribution, apoptosis, caspases activities and mitochondrial function in leukemia CCRF-CEM
cell line.
Methods: A resazurin assay was used to assess the cytotoxicity of the extracts on a panel of human cancer cell
lines whilst the microbroth dilution was used to determine the minimal inhibitory concentration (MIC) of the
samples against twelve bacterial strains belonging to four species, Escherichia coli, Enterobacter aerogenes, Klebsiella
pneumoniae and Pseudomonas aeruginosa.
Results: The best activity on leukemia cell lines were recorded with SY177 (IC50 of 9.94 μg/mL) and SY179 (IC50 of
1.81 μg/mL) against CCRF-CEM as well as Ach-b (IC50 of 9.30 μg/mL) and SY160 (IC50 of 5.06 μg/mL) against HL60
cells. The extracts from SY177 and SY179 were also toxic against the seven solid cancer cell lines studied with the
highest IC50 values of 31.64 μg/mL (SY177 against Hep-G2 cells). SY177 and Ach-b induced cell cycle arrest in
G0/G1 and S phases whilst SY160 and SY179 induced arrest in G0/G1 phase. All the four plant extracts induced
apoptosis in CCRF-CEM cells with the alteration of the mitochondrial membrane potential. In the antibacterial
assays, only Ach-b displayed moderate antibacterial activities against E. coli and E. aerogenes ATCC strains (MIC of
256 μg/mL), AG100ATeT and K. pneumoniae ATCC strains (MIC of 128 μg/mL).
Conclusions: Finally, the results of the present investigation provided supportive data for the possible use of some
Saudi Arabian plants investigated herein, and mostly Haplophyllum tuberculatum, Pulicaria crispa, Ononis serrata and
Achillea beiberstenii in the control of cancer diseases.
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Medicinal plants constitute an important source of new
candidates for therapeutic compounds, in regards to the
chemical diversity found in several species. Many plant-
derived compounds are currently successfully employed
in cancer chemotherapy, explaining the endeavor of re-
searchers worldwide for the intensive search of new
anti-neoplastic agents from the nature. The flora of
Saudi Arabia is one of the richest biodiversity areas in
the Arabian Peninsula and comprises very important
genetic resources of crop and medicinal plants [1]. It
was estimated that the flora of Saudi Arabia has a great
medicinal species diversity, which is expected to be
more than 1200 (over 50%) out of its 2250 species [1].
Hence, the present study was designed to investigate the
cytotoxicity and the antimicrobial activities of twenty
six Saudi Arabian plants against leukemia and carcin-
oma cell lines. In addition, the effects of the four best
plants namely Haplophyllum tuberculatum, Pulicaria
crispa, Ononis serrata and Achillea beiberstenii on cell
cycle distribution, apoptosis, caspases activities and




All the plants were collected from Tanhat protected area
except Cleome ambliocarpa, Artemisia monosperma, Ono-
nis serrata and Achillea beibersteni that were collected
from Um-Rugum, Aldahua, Kaba and Albaha, respect-
ively, (Saudi Arabia) in March 2010. The plants were iden-
tified by the Plants Taxonomy and Herbarium Unit. The
voucher specimens (Table 1) have been deposited at the
Herbarium of the Faculty of Pharmacy, King Saud Univer-
sity, Riyadh, Saudi Arabia.
Extraction
The aerial parts of plants were collected and dried under
shade. The dried samples were powdered and used for
solvent extraction. For extract preparation, 100 g of dried
sample was extracted with 80% methanol for 48 h and the
procedure was repeated once. The extracts were filtrated
through Whatman No. 1 and combined, then concentrated
using a rotary evaporator under reduced pressure at 40°C.
The dry extract obtained with each solvent was weighed.
The percentage yield was expressed in terms of air dried
weight of plant materials.
Chemicals
Doxorubicin, vinblastine and daunorubicin from Sigma-
Aldrich (Munich, Germany) were dissolved in Phosphate
Buffer Saline (PBS; Invitrogen, Eggenstein, Germany) at
a concentration of 10 mM. Geneticin was purchased
from Sigma-Aldrich at a concentration of 50 mg/mL insterile-filtered water. Chloramphenicol (Sigma-Aldrich,
St Quentin Fallavier, France) was used as reference anti-
bacterial drug.
Cell cultures
Leukemia CCRF-CEM and HL-60 cells were maintained
in RPMI 1640 medium (Invitrogen) supplemented with
10% fetal calf serum in a humidified 5% CO2 atmosphere
at 37°C. Cells were kindly provided by Dr. J. Beck (Depart-
ment of Pediatrics, University of Greifswald, Greifswald,
Germany). Breast cancer cells transduced with control
vector (MDA-MB-231-pcDNA3) or with cDNA for the
breast cancer resistance protein BCRP (MDA-MB-231-
BCRP clone 23) were maintained under standard condi-
tions as described above for CCRF-CEM and HL-60 cells.
Human wild-type HCT116 (p53+/+) colon cancer cells as
well as knockout clones HCT116 (p53−/−) derived by
homologous recombination were a generous gift from Dr.
B. Vogelstein and H. Hermeking (Howard Hughes Med-
ical Institute, Baltimore, MD). Non-transduced human
glioblastoma multiforme U87MG cells and U87MG cells
transduced with an expression vector harboring an epi-
dermal growth factor receptor (EGFR) gene with a gen-
omic deletion of exons 2 through 7 (U87MG.ΔEGFR)
were kindly provided by Dr. W. K. Cavenee (Ludwig In-
stitute for Cancer Research, San Diego, CA). MDA-MB-
231-BCRP, U87MG.ΔEGFR and HCT116 (p53−/−) were
maintained in DMEM medium containing 10% FBS
(Invitrogen) and 1% penicillin (100 U/mL)-streptomycin
(100 μg/mL) (Invitrogen) and were continuously treated
with 800 ng/mL and 400 μg/mL geneticin, respectively.
The multidrug resistance profile of these cell lines has
been reported [32]. Human HepG2 hepatocellular car-
cinoma cells and the AML 12 normal heptocytes were
obtained from the American Type Cell Culture Collec-
tion ATCC (USA). DMEM medium without geneticin
was used to maintain MDA-MB-231, U87MG, HCT116
(p53+/+), HepG2 and AML 12 cell lines. The cells were
passaged twice weekly. All experiments were performed
with cells in the logarithmic growth phase.
Resazurin reduction assay
Resazurin reduction assay [33] was performed to assess
the cytotoxicity of the crude extracts towards various sen-
sitive and resistant cancer cell lines. The assay is based on
reduction of the indicator dye, resazurin, to the highly
fluorescent resorufin by viable cells. Non-viable cells rap-
idly lose their metabolic capacity to reduce resazurin and,
thus, do not produce fluorescent signals anymore. Briefly,
adherent cells were detached by treatment with 0.25%
trypsin/EDTA (Invitrogen) and an aliquot of 1 × 104 cells
was placed in each well of a 96-well cell culture plate
(Thermo Scientific, Germany) in a total volume of 200 μL.
Cells were allowed to attach overnight and then were
Table 1 Medicinal plants used in the present study
Plant species/Family (Voucher specimen) Traditional use Sample used*
(yield in %)
Index
Teucrium oliverianum/Lamiaceae (15930) Antinociceptive effect [2], antioxidant activity [3] and antimicrobial activities [4] 20.0 SY-175
Echium arabicum/Boraginaceae (15931) Antiplasmodial and antitrypanosomal activity [5] 14.5 SY-176
Haplophyllum tuberculatum/Rutaceae (15932) Headaches and arthritis, to remove warts and freckles from the skin and also to treat
skin discoloration, infections and parasitic diseases [6], it is used to treat malaria,
rheumatoid arthritis and gynecological disorders [7]
19.6 SY-177
Senna italica/Caealpiniaceae (15933) Diarrhea, stomachache, female infertility, tuberculosis, asthma [8] 14.9 SY-178
Pulicaria crispa/Asteraceae (15934) Treat inflammation and an insect repellent [9] and is also used as an herbal tea 6.7 SY-179
Rhantarium epapposum/Asteraceae (15935) Skin infections and gastrointestinal disturbances and as an insecticide [10] 3.1 SY-180
Rumex vasicanus/Polygonaceae (15936) Treatment of pain, inflammation, bleeding, tinea, tumor, and constipation [11,12],
cough, headache, and fever [13]
13 SY-181
Ducrosia anethifolia/Aplaceae (15937) Analgesic and pain reliever for headache, ackache, colic, and colds [14] 26 SY-182
Heliotropium ramosissimum/Boraginaceae (15938) Treatment of gout, rheumatism, and as anti-inflammatory and healing agents [15] 2.58 SY-183
Picris cyanocarpa/Asteraceae (15939) Treatment of indigestion, against intestinal nematodes and other parasites [16] 19.5 SY-184
Anthemis deserti/Asteraceae (15940) Herbal medicines, insecticides, and dyes, food additives, as well as an important
source in aromatic and cosmetic industries [17]
10.8 SY-185
Cleome ambliocarpa/Cleomaceae (15945) Stomachics, rubefacients and in the treatment of scabies, rheumatic, fever,
inflammation and a hypoglycemic agent, [18]
14.9 SY-186
Zilla spinosa/Brassicaceae (15946) Antioxidant, antifungal, hepatoprotective and antiviral activities [19] 13.5 SY-187
Ziziphus nummularia/Rhamnaceae (15947) Antibacterial, analgesic activities and anthelmintics [20] 11.6 SY-188
Neurada procumbens/Neuradaceae (15949) Diarrhea and dysentery; as well, it has been used as a tonic to ‘increase heart and
respiration functions
8.6 SY-189
Trigonella hamosa/Papilionaceae (15951) A condiment and seasoning in food preparations and hypoglycemic 22 SY-190
Achillia fragrantissima/Asteraceae (15952) Respiratory diseases and gastrointestinal disturbances [21] 6.2 SY-191
Convolvulus prostates/Convolvulaceae (15953) Brain related disease, improve memory, skin disease [22] 15.3 SY-192
Cltrullus colocynthis/Cucurbitaceae (15954) Treat constipation, diabetes, edema, fever, jaundice, bacterial infections as well as
cancer [23]
14.2 SY-193
Emex spinosa/Polygonaceae (15955) Purgative, diuretic, a remedy for stomach disorders, dyspepsia and colic [24] 16.8 SY-194
Rhazya strict/Apocynaceae (15957) Diabetes mellitus, fever, sore throat, inflammatory conditions and helminthiasis [25] 22 SY-195
Scrophularia hypericifolia/Scrophulariaceae (15958) Antipyretic, febrifuge and anti-bacterial, as a remedy for evening fever, mouth dry-
ness, constipation, prurigo, furunculosis, sore throat, ulcerous stomatitis, tonsillitis and
in the treatment of cancer [26,27]
12.12 SY-196
Caylusea hexagyna/Resedaceae (15959) Anticancer (melanoma cell lines) [28] 13.04 SY-197
























Table 1 Medicinal plants used in the present study (Continued)
Ononis serrata/Fabaceae (15925) Antibiotic, antipyretic, anti-inflammatory, antifungal and antiseptic activities. Treat-
ment of skin and rheumatic diseases as well as gout [30]
5.5 SY160
Achillea beiberstenii/Asteraceae (15470) Spasmolytic, choleretic, treatment of wounds and anti-inflammatory activities, make it
as an important medicinal plant [31]
10.4 Ach-b
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suspension cells, aliquots of 2 × 104 cells per well were
seeded in 96-well-plates in a total volume of 100 μL. The
studied sample was immediately added in varying concen-
trations in an additional 100 μL of culture medium to ob-
tain a total volume of 200 μL/well. After 24 h or 48 h,
20 μL resazurin (Sigma-Aldrich, Germany) 0.01% w/v in
double distilled water (ddH2O) was added to each well
and the plates were incubated at 37°C for 4 h. Fluores-
cence was measured on an Infinite M2000 Pro™ plate
reader (Tecan, Germany) using an excitation wavelength
of 544 nm and an emission wavelength of 590 nm. Each
assay was done at least two times, with six replicate each.
The twenty six studied plants were first tested on CCRF-
CEM and HL60 at 40 μg/mL and samples inducing less
than 50% growth proliferation were further diluted serially
(in a concentration ranges of 0.33 to 40 μg/mL) and tested
for IC50 determinations. Afterwards, samples with IC50
value below and around 30 μg/mL on the above leukemia
cells were further tested on the solid cancer cells in a con-
centration ranges of 0.33 to 40 μg/mL. The viability was
evaluated based on a comparison with untreated cells.
IC50 values represent the compound’s concentrations re-
quired to inhibit 50% of cell proliferation and were calcu-
lated from a calibration curve by linear regression using
Microsoft Excel.
Determination of cell cycle distribution and apoptosis by
flow cytometry
The cell cycle analysis was performed by flow cytometry
using the Vybrant® DyeCycle™ Violet (Invitrogen). This
dye is a DNA-selective, cell membrane-permeant, and
non-fluorescent stain that uses the violet laser for DNA
content analysis in living cells. Vybrant® DyeCycle™ Vio-
let is fluorescent upon binding to double-stranded DNA.
Leukemia CCRF-CEM cells (1 × 106) were treated with
concentrations equivalent to the IC50 values of the four
most active plant extracts namely those from Ononis ser-
rata (SY160), Haplophyllum tuberculatum (SY177),
Pulicaria crispa (SY179), and Achillea beiberstenii (SY-
200), for 24 h. Following incubation, 1 μL of Vybrant®
DyeCycle™ Violet was added to 1 mL of cell suspension
and incubated for 30 min at 37°C. Cells were measured
on a LSR-Fortessa FACS analyzer (Becton-Dickinson,
Germany). For each sample 104 cells were counted.
Vybrant® DyeCycle™ Violet was measured at an excita-
tion of 440 nm. Cytographs were analyzed using FlowJo
software (Celeza, Switzerland).
Caspase-Glo 3/7, caspase-Glo 8 and caspase-Glo 9 assay
The influence of extracts SY160, SY177, SY179, and Ach-b
on caspase 3/7, caspase 8 and caspase 9 activities in CCRF-
CEM leukemia cells was detected using Caspase-Glo 3/7,
Caspase-Glo 8 and Caspase-Glo 9 Assay kits (Promega,Germany). Cells cultured in RPMI were seeded in 96-well
plates and treated with the sample (2 × IC50 and IC50) or
DMSO (solvent control). After 6 h treatment, 100 μL of
caspase reagent were added to each well, mixed and incu-
bated for 1 h at room temperature. Luminescence was
measured using well Infinite M2000 Pro™ instrument
(Tecan). Caspase activity was expressed as percentage of
the untreated control.
Analysis of mitochondrial membrane potential (MMP)
The effects of extracts SY160, SY177, SY179, and Ach-b on
the MMP were analyzed by 5,5′,6,6′-tetrachloro-1,1′,3,3′-
tetraethylbenzimidazolylcarbocyanine iodide) (JC-1; Bio-
mol, Germany) staining. JC-1 is a dye that can selectively
enter into mitochondria and exhibits an intense red and
green fluorescence in healthy mitochondria with normal
membrane potentials. In cells with reduced MMP, the red
fluorescence disappears and the unhealthy cells show only
green fluorescence. Briefly, 1 × 106 CCRF-CEM cells treated
with different concentrations of compound or DMSO (solv-
ent control) for 24 h were incubated with JC-1 staining so-
lution according to the manufacturer’s protocol for 30 min.
Subsequently, cells were measured in a LSR-Fortessa FACS
analyzer (Becton-Dickinson). For each sample, 1 × 104 cells
were counted. The red JC-1 signal was measured with
561 nm excitation (150 mW) and detected using a 586/
15 nm bandpass filter. The green JC-1 signal was analyzed
with 488 nm excitation (25 mW) and detected using a 530/
30 nm bandpass filter. All parameters were plotted on a
logarithmic scale. Cytographs were analyzed using FlowJo
software (Celeza, Switzerland).
Antibacterial assay
Bacterial strains and culture media
The studied microorganisms included the reference
(from the American Type Culture Collection) and
multidrug-resistant (MDR) clinical strains of Escheri-
chia coli (ATCC8739 and AG100ATET), Enterobacter
aerogenes (ATCC13048 and CM64), Klebsiella pneumo-
niae (ATCC11296 and KP63) and Pseudomonas aerugi-
nosa (PA01 and PA124). They were maintained in
Nutrient Broth supplemented at 4°C and activated on a
fresh appropriate Mueller Hinton Agar plates 24 h prior
to any antimicrobial test. The Mueller Hinton Broth
(MHB) was also used for the all antibacterial assays.
Bacterial susceptibility determinations
The MICs were determined using the rapid INT colori-
metric assay [34,35]. Briefly, the test samples were first
dissolved in DMSO/MHB. The solution obtained was
then added to MHB, and serially diluted two fold (in a
96- wells microplate). One hundred microlitres (100 μL)
of inoculum (1.5 × 106 CFU/mL ) prepared in MHB was
then added. The plates were covered with a sterile plate
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using a shaker and incubated at 37°C for 18 h. The final
concentration of DMSO was 2.5% and does not affect
the microbial growth. Wells containing MHB, 100 μL of
inoculum and DMSO at a final concentration of 2.5%
served as negative control (this internal control was sys-
tematically added). Chloramphenicol was used as refer-
ence antibiotic. The MICs of samples were detected
after 18 h incubation at 37°C, following addition of
40 μL of a 0.2 mg/mL INT solution and incubation at
37°C for 30 minutes. Viable bacteria reduce the yellow
dye to pink. MIC was defined as the lowest sample con-
centration that exhibited complete inhibition of micro-
bial growth and then prevented this change [36]. All
assays were performed in triplicate and repeated thrice.
Statistical analysis
Statistical analysis of all data was performed using a Stu-
dent’s t-test or Kruskal–Wallis test followed by Dunn’s
post-hoc multiple comparison test (Graph-Pad Prism
5.01; GraphPad Software, Inc., CA, USA). A significance
level of P < 0.05 denoted significance in all cases.
Results
Cytotoxicity
In the present work, the cytotoxicity of twenty six Saudi
Arabian plants (Table 1) was initially evaluated against
leukemia CCRF-CEM and HL60 cell lines. The results
depicted in Figure 1 show that only the extract from Helio-
tropium ramosissimum (SY183) did not prevent the growth
of the two cell line. Besides, those from Teucrium oliveria-
num (SY175), Echium arabicum (SY176) and Emex spi-
nosa (SY194) did not prevented the growth of CCRF-CEM




































































































Figure 1 Inhibitory percentage (%) of plant extracts at 40 μg/mL and
cell lines. Data with different superscript letters are significantly different (Pextents the proliferation of CCRF-CEM as well as HL60
cells. More than 50% inhibition of the growth of CCRF-
CEM and HL60 were exhibited by the extracts from
Achillea beiberstenii (SY-200; 76.27% and 66.22% re-
spectively) as well as Ononis serrata (SY160; 64.32% and
71.16% respectively). Also, more than 50% growth in-
hibition of CCRF-CEM was recorded with Haplophyl-
lum tuberculatum (SY177; 63.21%), Senna italica
(SY178; 53.57%), Pulicaria crispa (SY179; 76.17%),
Rhantarium epapposum (SY180; 66.71%), Anthemis
deserti (SY185; 65.54%), Ziziphus nummularia (SY188;
74.99%), Rhazya strict (SY195; 66.63%) and Artemisia
monosperma (SY198; 67.66%). The IC50 values of the ten
above samples were then determined on CCRF-CEM cells
whilst those of Ach-b and SY160 were evaluated on HL60
cells (Table 2). Apart from SY178 (IC50 value of 37.13 μg/
mL) and SY180 (IC50 value of 37.13 μg/mL) against
CCRF-CEM cells, other tested extracts displayed values
below or around 30 μg/mL. The best activities were re-
corded with SY177 (IC50 of 9.94 μg/mL) and SY179 (IC50
of 1.81 μg/mL) against CCRF-CEM as well as Ach-b (IC50
of 9.30 μg/mL) and SY160 (IC50 of 5.06 μg/mL) against
HL60 cells. Samples with IC50 value below and around
30 μg/mL (SY177, SY179, SY185, SY188, SY189, SY198,
SY160 and Sch-b) were further tested on the solid cancer
cells (Table 3) including both sensitive and resistant phe-
notypes. The results showed that only the extracts from
SY177 and SY179 were toxic to the seven solid cancer
cells with the highest IC50 values of 31.64 μg/mL (SY177
against Hep-G2 cells). Other samples showed selective ac-
tivities, the extracts of SY160 and Ach-b being active on
six of the seven solid cancer cells tested. Consequently,
the extracts SY160, SY177, SY179, and Ach-b which























































































doxorubicin (10 μg/mL) on leukemia CCRF-CEM and HL60 cancer
< 0.05).
Table 2 IC50 values of Saudi Arabian plants towards
leukemia cancer cell lines CCRF-CEM and HL60 as deter-
mined by the resazurin assay
Tested samples Samples
code
Cell lines and IC50 (μg/mL)
CCRF-CEM HL60
Haplophyllum tuberculatum SY177 9.94 -
Senna italica SY178 37.13 -
Pulicaria crispa SY179 1.81 -
Rhantarium epapposum SY180 31.9 -
Anthemis deserti SY185 30.08 -
Ziziphus nummularia SY188 16.6 -
Rhazya strict SY195 22.35 -
Artemisia monosperma SY198 19.64 -
Ononis serrata SY160 17.44 9.30
Achillea beiberstenii SY-200 18.11 5.06
Doxorubicin 0.11 0.40
(−): >40 μg/mL.
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pase 3/7, 8 and 9 activities as well as on MMP using
CCRF-CEM cells as model for the studies.
Cell cycle distribution and apoptosis
The effects of extracts SY160, SY177, SY179, and Ach-b
on the cell cycle distribution of CCRF-CEM cells are sum-
marized in Figure 2. All the four extracts as well as doxo-
rubicin considerably altered the distribution of the
different cell cycle phases after 24 h. All the four extracts
also significantly induced apoptosis after 24 h treatment
with percentages of sub-G0/G1 phase of 14.6% for SY177,
66.9% for SY179, 40.2% for Ach-b and 65.7% for SY160.
Effect on the mitochondrial membrane potential (MMP)
Since the breakdown of the MMP is amongst the se-
quences of events occurring during the apoptoticTable 3 Cytotoxicity of Saudi Arabian plants towards sensitiv
cells as determined by the resazurin assay
Tested samples Sample
code





Haplophyllum tuberculatum SY177 11.92 26.65 (2.24)
Pulicaria crispa SY179 14.6 8.37 (0.57)
Anthemis deserti SY185 - -
Ziziphus nummularia SY188 - -
Neurada procumbens SY189 - -
Artemisia monosperma SY198 - 26.16 (<0.65)
Ononis serrata SY160 19.28 25.09 (1.30)
Achillea beiberstenii SY-200 10.48 22.32 (2.13)
Doxorubicin 1.10 7.83 (7.12)
(*): The degree of resistance was determined as the ratio of IC50 value of the resistapathway, we assessed the involvement of extracts SY160,
SY177, SY179, and Ach-b as well as that of the reference
drug vinblastine in the process. The results summarized
in Figure 3 show that the four extracts as well as vin-
blastine were able to alter the MMP in CCRF-CEM
upon 24 h treatment. When cells were treated with con-
centrations equivalent to the IC50 values of the samples,
percentages of alterations of the MMP observed were
found to be 16.7%, 27.7%, 27.8% and 28.0% respectively
for Ach-b, SY160, SY177, and SY179. However, such al-
teration was still lower than that of vinblastine (48.6%).
Effect on the activity of caspases 3/7, 8 and 9
The influence of extracts SY160, SY177, SY179, and
Ach-b on caspases 3/7, 8 and 9 activities in CCRF-CEM
cells were investigated. None of the four samples in-
duced the activation of each of the studied enzymes
(data not shown).
Antimicrobial activity
The twenty six plant extracts tested for their cytotoxicity
were also, screened for their antibacterial activities
against eight bacterial strains belonging to four species,
Escherichia coli, Enterobacter aerogenes, Klebsiella pneu-
moniae and Pseudomonas aeruginosa. Only Ach-b dis-
played moderate antibacterial activities against E. coli
and E. aerogenes ATCC strains (MIC of 256 μg/mL),
AG100ATeT and K. pneumoniae ATCC strains (MIC of
128 μg/mL). This extracts as well as the twenty-five
others were not active on bacterial species.
Discussion
According to the criteria of the American National Can-
cer Institute, as reported by Suffness and Pezzuto [37],
30 μg/mL is the upper IC50 limit considered promising









2.42 3.30 (1.36) 15.03 27.67 (1.84) 31.64 -
2.79 2.58 (0.92) 4.31 27.46 (6.37) 27.85 -
24.48 31.94 (1.30) - - - -
- - - - - -
- - 3.01 - - -
7.35 6.65 (0.90) 25.25 24.95 (0.99) - -
14.9 21.94 (1.47) 28.58 31.09 (1.09) - -
17.09 17.31 (1.01) - 19.24 (<0.48) 27.28 -
1.41 4.06 (2.88) 1.06 6.11 (5.76) 1.41 -
nt/IC50 sensitive cell line; (−): >40 μg/mL.
control SY177 SY179
Ach-b SY160 Doxorubicin
Figure 2 Cell cycle distribution of leukemia CCRF-CEM cells treated with selected plant extracts and doxorubicin at their IC50 values for 24 h.
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slightly above this limit. Herein, IC50 values below 30 μg/
mL were recorded with the crude extract from SY160 and
Ach-b against the two leukemia cell lines, CCRF-CEM and
HL60 (Table 2). In addition, the two plant extracts also dis-
played cytotoxic activities with IC50 values below 30 μg/mL
against six of the seven solid cancer cells (Table 3). This
highlights the role of these two plants as potential source
of products to combat both hematological and solid can-
cers. Also the extracts from SY177 and SY179 showed
good activities against the leukemia CCRF-CEM cells (IC50
value of 9.94 and 1.81 μg/mL respectively) and all the
seven studied solid cancer cells, with the IC50 values below
10 μg/mL against MDA-MB231-BCRP (8.37 μg/mL for
SY179), HCT116 WT (2.42 μg/mL for SY177 and 2.79 μg/
mL for SY179). HCT116 (p53−/−) (3.30 μg/mL for SY177
and 2.58 μg/mL for SY179) and against U78MG (2.58 μg/
mL for SY179). These data also suggest that the two plant
extracts can be potential source of cytotoxic agents. This is
remarkable, since the extracts also exhibited considerable
activity towards genetically modified cell lines, which
harbor cDNAs encoding for proteins mediating resistance
to standard anticancer drugs, such as the breast cancerresistance protein (BCRP) and an mutation-activated epi-
dermal growth factor receptor (EGFR) or which were
knocked-out in the expression of the tumor suppressor
p53. Importantly, the degrees of resistance of the four
most active plant extracts Ononis serrata (SY160), Haplo-
phyllum tuberculatum (SY177), Pulicaria crispa (SY179),
and Achillea beiberstenii (SY-200) were generally lower
than that of doxorubicin for the corresponding drug-
resistant cell lines (Table 3). Besides, collateral sensitivity
(resistant cells being more sensitive than their sensitive
parental cell lines with degrees of resistance below 1) was
observed with each of the four plant extracts on at least
one MDR cell lines (Table 3). This suggests that the ex-
tracts from Haplophyllum tuberculatum, Pulicaria crispa,
Ononis serrata and Achillea beiberstenii might be useful
to fight MDR cancer cells. Interestingly, normal AML12
hepatocytes were more resistant to the extracts than
HepG2 hepatocellular carcinoma cells. This may be taken
as a hint that these compounds exhibit some tumor spe-
cificity, although their toxicity towards normal organs
needs to be further explored. Consequently, the four
best plant extracts, namely those from Ononis serrata
(SY160), Haplophyllum tuberculatum (SY177), Pulicaria
Figure 3 Effect of selected plant extracts and vinblastine on the MMP of CCRF-CEM cells after 24 h treatment at their IC50 values; The
IC50 values: 0.20 μM for VIN (this study). Samples: control (A), vinblastine (B), SY177 (C), SY179 (D), Ach-b (E), SY160 (F). Q1 represent cells with
healthy MMP whilst Q2-Q4 are those with altered MMP.
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lected for further mechanistic studies. It was observed that
SY160, SY177, SY179, and Ach-b induce apoptosis in
leukemia CCRF-CEM cells (Figure 2). The percentages of
sub-G0/G1 phase upon treatment with SY160 (65.7%) and
SY179 (66.9%) were higher than those of doxorubicin
(52.1%) (Figure 2) highlighting their strong apoptotic in-
ducing effects. SY177 and Ach-b induce cell cycle arrest
in G0/G1 and S phases whilst SY160 and SY179 induce
arrest in G0/G1 phase (Figure 2). Caspases, or cysteine-
aspartic proteases are a family of cysteine proteases that
play essential roles in apoptosis, necrosis, and inflamma-
tion [38]. As the extracts SY160, SY177, SY179, and Ach-
b were found to strongly induce apoptosis in CCRF-CEM
cells (Figure 2), we evaluated the involvement of initiator
caspases 8 and 9 as well as that of effector caspases 3
and 7 in this process. Unfortunately, none of the four
studied extracts (SY160, SY177, SY179, and Ach-b) acti-
vated these enzymes (data not shown), suggesting that it
is not the main pathways involved in apoptosis in
CCRF-CEM cells. Hopefully, when assaying their effects
on MMP, the four plant extracts were found to inducethe dysfunction of the mitochondrial membrane in CCRF-
CEM cells (Figure 3). The alteration of the MMP can
therefore be suggested as one of the possible mechanisms
of apoptosis induced by SY160, SY 177, SY179, and Ach-b.
Phytochemicals are routinely classified as antimicro-
bials on the basis of susceptibility tests that produce
MIC in the range of 100 to 1000 mg/mL [39]. Activity is
considered to be significant if MIC values are below
100 μg/mL for crude extracts and moderate when 100 <
MIC < 625 μg/mL [40]. In this study, only Ach-b dis-
played moderate antibacterial activities against E. coli
and E. aerogenes and K. pneumoniae. Therefore, none of
the studied samples could be considered as promising
source of antimicrobial compounds.
Conclusions
Finally, the results of the present investigation highlight
the cytotoxic potential of the studied Saudi Arabian me-
dicinal plant extracts, especially those from Haplophyl-
lum tuberculatum, Pulicaria crispa, Ononis serrata and
Achillea beiberstenii. The isolation of active constituents
from these plants will further be performed.
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